Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪3.40 B‬USD
−5.20USD
‪−239.24 M‬USD
‪270.60 M‬USD
‪38.78 M‬
Beta (1Y)
0.99

About Axsome Therapeutics, Inc.

CEO
Herriott Tabuteau
Website
Headquarters
New York
Employees (FY)
545
Founded
2012
ISIN
US05464T1043
FIGI
BBG00B6G7GL7
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AXSM is 69.15 USD — it has decreased by 3.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Axsome Therapeutics, Inc. stocks are traded under the ticker AXSM.
Axsome Therapeutics, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Axsome Therapeutics, Inc. has a max estimate of 190.00 USD and a min estimate of 90.00 USD.
AXSM earnings for the last quarter are −1.32 USD whereas the estimation was −1.20 USD which accounts for −9.70% surprise. Estimated earnings for the next quarter are −1.17 USD. See more details about Axsome Therapeutics, Inc. earnings.
Axsome Therapeutics, Inc. revenue for the last quarter amounts to ‪57.79 M‬ USD despite the estimated figure of ‪54.87 M‬ USD. In the next quarter revenue is expected to reach ‪69.24 M‬ USD.
Yes, you can track Axsome Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, AXSM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Axsome Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AXSM reached its all-time high on Dec 30, 2019 with the price of 109.94 USD, and its all-time low was 1.94 USD and was reached on Dec 27, 2018.
See other stocks reaching their highest and lowest prices.
As of Apr 13, 2024, the company has 545.00 employees. See our rating of the largest employees — is Axsome Therapeutics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Axsome Therapeutics, Inc. EBITDA is ‪−174.96 M‬ USD, and current EBITDA margin is −65.07%. See more stats in Axsome Therapeutics, Inc. financial statements.